J&J COVID-19 vaccine pause lifted; CDC, FDA find benefits outweigh risks

The Johnson & Johnson COVID-19 vaccine pause has been lifted after a CDC advisory panel vote and review from health officials. The pause lasted more than a week after a handful of blood clots and several deaths were reported out of about 7 million doses administered. NBC’s Sam Brock reports for Weekend TODAY.